Irenic Capital Management’s Theravance Biopharma TBPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $30.5M | Hold |
2,760,948
| – | – | 4.49% | 6 |
|
|
2025
Q1 | $24.7M | Hold |
2,760,948
| – | – | 3.74% | 8 |
|
|
2024
Q4 | $26M | Hold |
2,760,948
| – | – | 2.79% | 12 |
|
|
2024
Q3 | $22.3M | Hold |
2,760,948
| – | – | 1.95% | 11 |
|
|
2024
Q2 | $23.4M | Hold |
2,760,948
| – | – | 2.86% | 6 |
|
|
2024
Q1 | $24.8M | Hold |
2,760,948
| – | – | 5.05% | 6 |
|
|
2023
Q4 | $31M | Hold |
2,760,948
| – | – | 6.15% | 5 |
|
|
2023
Q3 | $23.8M | Hold |
2,760,948
| – | – | 6.76% | 3 |
|
|
2023
Q2 | $28.6M | Sell |
2,760,948
-3,100
| -0.1% | -$32.1K | 8.53% | 3 |
|
|
2023
Q1 | $30M | Buy |
2,764,048
+1,063,111
| +63% | +$11.5M | 10.35% | 3 |
|
|
2022
Q4 | $19.1M | Buy |
+1,700,937
| New | +$19.1M | 9.15% | 3 |
|